Počet záznamů: 1  

Development of a human vasopressin V-1a-receptor antagonist from an evolutionary-related insect neuropeptide

  1. 1.
    SYSNO ASEP0474787
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevDevelopment of a human vasopressin V-1a-receptor antagonist from an evolutionary-related insect neuropeptide
    Tvůrce(i) Di Giglio, M. G. (AT)
    Muttenthaler, M. (AU)
    Harpsoe, K. (DK)
    Liutkeviciute, Z. (AT)
    Keov, P. (AU)
    Eder, T. (AT)
    Rattei, T. (AT)
    Arrowsmith, S. (GB)
    Wray, S. (GB)
    Marek, Aleš (UOCHB-X) RID, ORCID
    Elbert, Tomáš (UOCHB-X) RID, ORCID
    Alewood, P. F. (AU)
    Gloriam, D. E. (DK)
    Gruber, C. W. (AT)
    Číslo článku41002
    Zdroj.dok.Scientific Reports. - : Nature Publishing Group - ISSN 2045-2322
    Roč. 7, Feb 1 (2017)
    Poč.str.15 s.
    Jazyk dok.eng - angličtina
    Země vyd.GB - Velká Británie
    Klíč. slovaneuropeptide ; inotocin ; V1aR-antagonist
    Vědní obor RIVCE - Biochemie
    Obor OECDBiochemistry and molecular biology
    Institucionální podporaUOCHB-X - RVO:61388963
    UT WOS000393163800001
    EID SCOPUS85011362911
    DOI10.1038/srep41002
    AnotaceCharacterisation of G protein-coupled receptors (GPCR) relies on the availability of a toolbox of ligands that selectively modulate different functional states of the receptors. To uncover such molecules, we explored a unique strategy for ligand discovery that takes advantage of the evolutionary conservation of the 600-million-year-old oxytocin/vasopressin signalling system. We isolated the insect oxytocin/vasopressin orthologue inotocin from the black garden ant (Lasius niger), identified and cloned its cognate receptor and determined its pharmacological properties on the insect and human oxytocin/vasopressin receptors. Subsequently, we identified a functional dichotomy: inotocin activated the insect inotocin and the human vasopressin V-1b receptors, but inhibited the human V1aR. Replacement of Arg8 of inotocin by D-Arg8 led to a potent, stable and competitive V1aR-antagonist ([D-Arg8]-inotocin) with a 3,000-fold binding selectivity for the human V1aR over the other three subtypes, OTR, V1bR and V2R. The Arg8/D-Arg8 ligand-pair was further investigated to gain novel insights into the oxytocin/vasopressin peptide-receptor interaction, which led to the identification of key residues of the receptors that are important for ligand functionality and selectivity. These observations could play an important role for development of oxytocin/vasopressin receptor modulators that would enable clear distinction of the physiological and pathological responses of the individual receptor subtypes.
    PracovištěÚstav organické chemie a biochemie
    Kontaktasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Rok sběru2018
    Elektronická adresahttps://www.nature.com/articles/srep41002
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.